APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
Authors
Keywords
HCV, HCC, DAA, SVR, Follow-up, Guideline, HBV
Journal
Hepatology International
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-20
DOI
10.1007/s12072-019-09988-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
- (2018) Chun-Jen Liu et al. GASTROENTEROLOGY
- Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals
- (2018) Francesca Faillaci et al. HEPATOLOGY
- Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
- (2018) Nancy Reau et al. HEPATOLOGY
- Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study
- (2018) Lai Wei et al. Hepatology International
- HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
- (2018) George N. Ioannou et al. JOURNAL OF HEPATOLOGY
- Rapidly growing, moderately differentiated HCC: A clinicopathological characteristic of HCC occurrence after IFN-free DAA therapy?
- (2018) Yasuhiko Nakao et al. JOURNAL OF HEPATOLOGY
- Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease
- (2018) Manoj Kumar et al. LIVER INTERNATIONAL
- Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments
- (2018) Hidenori Toyoda et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection
- (2018) Yoshihiko Ooka et al. Hepatology International
- Rapid hepatitis C virus clearance by antivirals correlates with immune status of infected patients
- (2018) Reina Sasaki et al. JOURNAL OF MEDICAL VIROLOGY
- Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication
- (2018) Hiroyuki Motoyama et al. PLoS One
- Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection
- (2018) Jacinta A. Holmes et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals
- (2017) Jacinta A. Holmes et al. Expert Opinion On Drug Safety
- Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
- (2017) Sabela Lens et al. GASTROENTEROLOGY
- Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
- (2017) Ira M. Jacobson et al. GASTROENTEROLOGY
- Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace
- (2017) Chih-Lin Lin et al. Hepatology International
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort
- (2017) Akira Doi et al. HEPATOLOGY RESEARCH
- Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals
- (2017) Ming-Lun Yeh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A
- (2017) Tomoki Ryu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada
- (2017) Naveed Z. Janjua et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
- (2017) Philippe Kolly et al. JOURNAL OF HEPATOLOGY
- Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
- (2017) Jose Luis Calleja et al. JOURNAL OF HEPATOLOGY
- Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
- (2017) Hiroko Nagata et al. JOURNAL OF HEPATOLOGY
- Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
- (2017) Claudio Zavaglia et al. JOURNAL OF HEPATOLOGY
- IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR
- (2017) C. Carlton-Smith et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management
- (2017) Z. Liu et al. JOURNAL OF VIRAL HEPATITIS
- Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy
- (2017) A. Tamori et al. JOURNAL OF VIRAL HEPATITIS
- Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C
- (2017) N. Kawagishi et al. JOURNAL OF VIRAL HEPATITIS
- Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens
- (2017) K. Rajender Reddy et al. LIVER INTERNATIONAL
- Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV
- (2017) Eiichi Ogawa et al. LIVER INTERNATIONAL
- Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
- (2017) Edward Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
- (2017) Marc Bourlière et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
- (2017) Chen-Hua Liu et al. Open Forum Infectious Diseases
- On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C
- (2017) Po-sung Chu et al. PLoS One
- Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
- (2017) María Buti et al. PLoS One
- Ledipasvir and sofosbuvir for HCV-infection in patients coinfected with HBV
- (2016) Edward J Gane et al. ANTIVIRAL THERAPY
- Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment
- (2016) Ming-Lung Yu et al. CLINICAL CANCER RESEARCH
- Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection
- (2016) Hashem B. El-Serag et al. HEPATOLOGY
- HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea
- (2016) Chung Hwan Jun et al. Hepatology International
- Prevention and management of hepatitis B virus reactivation in cancer patients
- (2016) Ka-Shing Cheung et al. Hepatology International
- APASL consensus statements and recommendation on treatment of hepatitis C
- (2016) Masao Omata et al. Hepatology International
- Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge
- (2016) Anne De Monte et al. JOURNAL OF CLINICAL VIROLOGY
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
- (2016) Fabio Conti et al. JOURNAL OF HEPATOLOGY
- The impact of direct-acting antivirals on early tumor recurrence after radiofrequency ablation in hepatitis C-related hepatocellular carcinoma
- (2016) Tatsuya Minami et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment
- (2016) Harrys A. Torres et al. JOURNAL OF HEPATOLOGY
- High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
- (2016) Helder Cardoso et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C
- (2016) Julia Hengst et al. JOURNAL OF INFECTIOUS DISEASES
- Ten-year follow-up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon-α and ribavirin therapy
- (2016) X. Wang et al. JOURNAL OF VIRAL HEPATITIS
- DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment
- (2016) Rosanna Villani et al. PLoS One
- Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
- (2015) Shigeru Kusumoto et al. CLINICAL INFECTIOUS DISEASES
- Reappearance of serum hepatitis B viral DNA in patients with hepatitis B surface antigen seroclearance
- (2015) Masato Nakamura et al. HEPATOLOGY
- Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection
- (2015) Aaron F. Carlin et al. HEPATOLOGY
- Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study
- (2015) Tsunenobu Sato et al. Hepatology International
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis
- (2015) L. Mozessohn et al. JOURNAL OF VIRAL HEPATITIS
- Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
- (2015) Masashi Mizokami et al. LANCET INFECTIOUS DISEASES
- Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients
- (2015) Tatsuya Minami et al. MEDICINE
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- (2015) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
- (2014) Masao Omata et al. JOURNAL OF VIRAL HEPATITIS
- Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center
- (2013) Jessica P Hwang et al. BMC CANCER
- A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C–Associated Liver Cirrhosis
- (2013) Soo Aleman et al. CLINICAL INFECTIOUS DISEASES
- α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C
- (2013) Yasuhiro Asahina et al. HEPATOLOGY
- Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
- (2013) Yi-Hsiang Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma
- (2013) Takashi Kumada et al. JOURNAL OF GASTROENTEROLOGY
- Characteristic Pattern of Reactivation of Hepatitis B Virus during Chemotherapy for Solid Cancers
- (2012) Satoru Hagiwara et al. DIGESTIVE DISEASES
- The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy
- (2011) Roberta D’Ambrosio et al. ANTIVIRAL THERAPY
- A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
- (2011) Meijun Long et al. BREAST CANCER RESEARCH AND TREATMENT
- Outcome of sustained virological responders with histologically advanced chronic hepatitis C
- (2010) Timothy R. Morgan et al. HEPATOLOGY
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
- (2010) Masao Omata et al. Hepatology International
- Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer
- (2010) Yoshimi Ide et al. Breast Cancer
- Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma
- (2009) Shigeru Kusumoto et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma
- (2008) Feng Wang et al. BMC CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started